We’re briefing on the Hill. This coming Tuesday, APC is holding a pharmacy compounding policy...
Fat cats to make drugs for fat cats? Like most people, you’ve probably thought, “Why hasn’t someone come up with weight-loss drugs for cats? Fear not — Okava Pharmaceuticals is on the case, planning to enroll 50 cats in a study of its GLP-1 drug, exenatide. No worries about giving Mittens a shot every week: This is a miniature implant that delivers the drug continuously for up to six months.
Tenille talks thyroid. APC Chief Advocacy Officer Tenille Davis was once again a guest on the Radio Health Journal show, this time talking about thyroid health with Dr. Anne Cappola from Penn — specifically, why certain patients are using desiccated thyroid extract, and what’s happening with the FDA’s threatened ban.
Stopping FDA’s “revolving door.” Too many FDA officials are leaving the agency only to take jobs with the very companies they were supposed to have been regulating. This erodes what little trust remains in the agency, argue Lee Rosebush (chairman of the Outsourcing Facilities Association) and Marc Wagner (a pharmacist-attorney) in “It’s past time to update the rules intended to slow the FDA’s revolving door” in Stat News. The agency’s post-employment rules need to change, they say … and they have a plan.
